Antimicrobial resistance of Streptococcus pneumoniae isolates of outpatients in Germany, 1999-2000

Chemotherapy

Volumn 50, Issue 4, 2004, Pages 184-189

  Reinert, Ralf René ^a   Lütticken, Rudolf ^a   Reinert, Susanne ^b   Al Lahham, Adnan ^a   Lemmen, Sebastian ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b SR Medical Communications GmbH   (Germany)

Author keywords

Germany; Macrolide; Resistance; Serotype; Streptococcus pneumoniae; Telithromycin

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; PENICILLIN G; ROXITHROMYCIN; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DILUTION; GERMANY; MICROBIAL SENSITIVITY TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTPATIENT; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; GERMANY; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MACROLIDES; MALE; MEMBRANE PROTEINS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OUTPATIENTS; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE;

EID: 8344221882     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080692     Document Type: Article

References (14)

1. Musher DM: Infections caused by Streptococcus pneumoniae: Clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis 1992;14:801-807.
2. Jones ME, Blosser-Middleton RS, Critchley IA, Thornsberry C, Sahm DF, Yamakita J, Akasaki M, Karlowsky JA: The activity of levofloxacin and comparator agents against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000. Chemotherapy 2002;48:232-237.
3. Garcia-De-Lomas J, Garcia-Rey C, Lopez L, Gimeno C: Susceptibility patterns of bacteria causing community-acquired respiratory infections in Spain: The SAUCE project. J Antimicrob Chemother 2002;50(suppl C):21-26.
4. Felmingham D, Reinert RR, Hirakata Y, Rodloff A: Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother 2002;50(suppl S1):25-37.
5. Reinert RR, Simic S, Al-Lahham A, Reinert S, Lemperle M, Lütticken R: Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: Results of a national surveillance study. J Clin Microbiol 2001;39:1187-1189.
6. Reinert RR, Al-Lahham A, Lemperle M, Tenholte C, Briefs C, Haupts S, Gerards HH, Lütticken R: Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany. J Antimicrob Chemother 2002;49:61-68.
7. Ackermann G, Rodloff AC: Drugs of the 21st century: Telithromycin (HMR 3647) - The first ketolide. J Antimicrob Chemother 2003;51:497-511.
8. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Sensitivity Testing. Supplemental Tables M100-S13, ed 13. Wayne, NCCLS, 2003.
9. Trieu-Cuot P, Poyart-Salmeron C, Carlier C, Courvalin P: Nucleotide sequence of the erythromycin resistance gene of the conjugative transposon Tn1545. Nucleic Acids Res 1990;18:3660.
10. Tait-Kamradt A, Davies T, Appelbaum PC, Depardieu F, Courvalin P, Petitpas J, Wondrack L, Walker A, Jacobs MR, Sutcliffe J: Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob Agents Chemother 2000;44:3395-3401.
11. Farrell DJ, Morrissey I, Bakker S, Felmingham D: Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study. J Antimicrob Chemother 2002;50(suppl S1):39-47.
12. Lemmen S, Al-Lahham A, Lütticken R, Reinert RR: In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany. Chemotherapy 2001;47:104-109.
13. Reinert RR, Al-Lahham A, Lütticken R, Boos M, Schmitz FJ: Characterization of clinical Streptococcus pneumoniae strains from Germany with decreased susceptibility to fluoroquinolones. J Antimicrob Chemother 2002;49:1015-1018.
14. Klugman KP: The successful clone: The vector of dissemination of resistance in Streptococcus pneumoniae. J Antimicrob Chemother 2002; 50(suppl C):1-6.